MEN2312

· Stemline Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEN2312, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer [Phase 1]